DK1165108T3 - Anvendelse af et ekstrakt af Serenoa repens til fremstilling af et lægemiddel til behandling af prostatacancer - Google Patents

Anvendelse af et ekstrakt af Serenoa repens til fremstilling af et lægemiddel til behandling af prostatacancer

Info

Publication number
DK1165108T3
DK1165108T3 DK00915254T DK00915254T DK1165108T3 DK 1165108 T3 DK1165108 T3 DK 1165108T3 DK 00915254 T DK00915254 T DK 00915254T DK 00915254 T DK00915254 T DK 00915254T DK 1165108 T3 DK1165108 T3 DK 1165108T3
Authority
DK
Denmark
Prior art keywords
prostate cancer
extract
drug
manufacture
treatment
Prior art date
Application number
DK00915254T
Other languages
Danish (da)
English (en)
Inventor
Pierre Fabre
Jean-Pierre Raynaud
Henri Cousse
Original Assignee
Pf Medicament
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pf Medicament filed Critical Pf Medicament
Application granted granted Critical
Publication of DK1165108T3 publication Critical patent/DK1165108T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
DK00915254T 1999-03-30 2000-03-30 Anvendelse af et ekstrakt af Serenoa repens til fremstilling af et lægemiddel til behandling af prostatacancer DK1165108T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9903959A FR2791573B1 (fr) 1999-03-30 1999-03-30 Utilisation d'un extrait de serenoa repens pour la fabrication d'un medicament destine au traitement du cancer de la prostate
PCT/FR2000/000804 WO2000057892A1 (fr) 1999-03-30 2000-03-30 Utilisation d'un extrait de serenoa repens pour la fabrication d'un medicament destine au traitement du cancer de la prostate

Publications (1)

Publication Number Publication Date
DK1165108T3 true DK1165108T3 (da) 2003-09-22

Family

ID=9543805

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00915254T DK1165108T3 (da) 1999-03-30 2000-03-30 Anvendelse af et ekstrakt af Serenoa repens til fremstilling af et lægemiddel til behandling af prostatacancer

Country Status (15)

Country Link
US (1) US6599540B1 (de)
EP (1) EP1165108B1 (de)
JP (1) JP2003504306A (de)
CN (1) CN1261142C (de)
AT (1) ATE241375T1 (de)
AU (1) AU774568B2 (de)
BR (1) BR0009445A (de)
CA (1) CA2370775C (de)
DE (1) DE60003010T2 (de)
DK (1) DK1165108T3 (de)
ES (1) ES2199802T3 (de)
FR (1) FR2791573B1 (de)
MX (1) MXPA01009879A (de)
PT (1) PT1165108E (de)
WO (1) WO2000057892A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003211877A1 (en) * 2002-03-11 2003-09-22 Takeda Chemical Industries, Ltd. Remedies for sex hormone-dependent disease
MX2007006254A (es) 2004-11-25 2007-09-07 Univ Melbourne Complejos de fosfato de calcio estabilizados.
WO2006065599A1 (en) * 2004-12-17 2006-06-22 Bionovo, Inc. Method of using extracts of epimedium species
US7482029B2 (en) 2005-04-01 2009-01-27 Bionovo, Inc. Composition for treatment of menopause
NZ563944A (en) 2005-06-07 2010-03-26 Univ Melbourne Dental mineralization with a protein disrupting agent in combination with stabilised amorphous calcium phosphate (ACP) and / or amorphous calcium fluoride phosphate (ACFP)
CN101208070B (zh) 2005-06-24 2011-08-31 墨尔本大学 离子络合物
US7700136B2 (en) * 2005-11-14 2010-04-20 Bionovo, Inc. Scutellaria barbata extract for the treatment of cancer
AU2007214265B2 (en) 2006-02-09 2012-06-14 The University Of Melbourne Fluoride composition and methods for dental mineralization
US20080319051A1 (en) * 2007-06-22 2008-12-25 Bionovo, Inc. Liquiritigenin and derivatives as selective estrogen receptor beta agonists
US20090042818A1 (en) * 2007-06-22 2009-02-12 Bionovo, Inc. Liquiritigenin and Derivatives as Selective Estrogen Receptor Beta Agonists
WO2009021196A1 (en) * 2007-08-08 2009-02-12 Bionovo, Inc. Extracts of ligustrum lucidum and uses thereof
WO2009033075A1 (en) * 2007-09-07 2009-03-12 Bionovo. Inc. ESTROGENIC EXTRACTS OF Scuttelaria barbata D. DON OF THE LABIATAE FAMILY AND USES THEREOF
JP2010538090A (ja) * 2007-09-07 2010-12-09 バイオノボ・インコーポレーテッド ユリ科ファミリーのクサスギカズラのエストロゲン性抽出物およびその使用
WO2009033099A1 (en) * 2007-09-07 2009-03-12 Bionovo, Inc. Estrogenic extracts of astragalus membranaceus fisch.bge.var.mongolicus bge. of the leguminosae family and uses thereof
CA2698739A1 (en) * 2007-09-07 2009-03-12 Bionovo, Inc. Estrogenic extracts of pueraria lobata willd. ohwi of the leguminosae family and uses thereof
US20090130118A1 (en) * 2007-11-19 2009-05-21 Bionovo, Inc. Scutellaria barbata extract and combinations for the treatment of cancer
CA2706330A1 (en) * 2007-11-19 2009-06-04 Bionovo, Inc. A process of making purified extract of scutellaria barbata d. don
US20090130101A1 (en) * 2007-11-19 2009-05-21 Bionovo, Inc. Anti-cancer therapy with an extract of scutellaria barbata
EP2219659A4 (de) * 2007-11-19 2010-11-17 Bionovo Inc Verfahren zum nachweis und zur behandlung von krebs mit einem extrakt aus scuttelaria barbata
DE102008012988A1 (de) 2008-03-07 2009-09-10 S.W. Patentverwertungs Ltd. Zusammensetzung und Verwendungen zur Beeinflussung des Haarwachstums
CA2721191A1 (en) * 2008-04-14 2009-10-22 Bionovo, Inc. Calycosin and analogs thereof for the treatment of estrogen receptor beta-mediated diseases
WO2009137534A2 (en) * 2008-05-06 2009-11-12 Bionovo, Inc. Estrogenic extracts for use in treating vaginal and vulvar atrophy
CA2726982A1 (en) * 2008-06-05 2009-12-10 Bionovo, Inc. Method of quantification of multiple bioactives from botanical compositions
WO2009148620A2 (en) * 2008-06-06 2009-12-10 Bionovo, Inc. Anthraquinones and analogs from rhuem palmatum for treatment of estrogen receptor beta-mediated conditions
DK2310023T3 (en) * 2008-07-31 2016-12-12 Sigma Tau Ind Farmaceuti COMPOSITION, WHICH INCLUDES green tea AND EXTRACT OF POMEGRANATE FOR USE IN PREVENTING OR REDUCING THE PROGRESSION OF PROSTATE CANCER
AU2009289644A1 (en) * 2008-09-03 2010-03-11 Bionovo, Inc. Methods and compositions for the treatment of cancer
WO2010129343A2 (en) * 2009-04-28 2010-11-11 Bionovo, Inc. Method of reducing fat accumulation and inducing weight loss
FR2963561B1 (fr) 2010-08-03 2013-04-12 Pf Medicament Composition pharmaceutique contenant un extrait de serenoa repens
NZ716163A (en) 2013-07-23 2019-09-27 Univ Melbourne Compositions and methods for dental mineralization
MX2016008482A (es) 2013-12-24 2016-10-26 Univ Melbourne Composiciones estannosas estabilizadas.
CZ306733B6 (cs) * 2014-08-27 2017-05-31 Walmark, A.S. Doplněk stravy na bázi klikvy velkoplodé pro použití k oddálení biochemického návratu karcinomu prostaty
SG11201907951QA (en) 2017-03-14 2019-09-27 Univ Melbourne Treatment for gingivitis

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2465486A1 (fr) * 1979-09-21 1981-03-27 Roussel Uclaf Nouvelle application utilisant la lh-rh ou des agonistes
FR2480754A1 (fr) * 1980-04-21 1981-10-23 Fabre Sa Pierre Procede d'obtention d'un extrait stable et desodorise de sabal serrulatum antiprostatique
IT1258305B (it) * 1992-04-10 1996-02-22 Zambeletti Spa L Composizioni farmaceutiche rettali per il trattamento dell'ipertrofia prostatica
US6039950A (en) * 1995-04-14 2000-03-21 University Of Southern California Pharmaceutical grade saw palmetto
US6107090A (en) * 1996-05-06 2000-08-22 Cornell Research Foundation, Inc. Treatment and diagnosis of prostate cancer with antibodies to extracellur PSMA domains
US5665393A (en) * 1996-09-03 1997-09-09 International Medical Research, Inc. Herbal composition for treating prostate carcinoma
US6197309B1 (en) * 1998-08-03 2001-03-06 Ronald E. Wheeler Prostate formula
US6482447B2 (en) * 1999-09-10 2002-11-19 Glenn Braswell Method and composition for the treatment of benign prostate hypertrophy (BPH) and prevention of prostate cancer
US6261607B1 (en) * 1999-10-19 2001-07-17 Thomas Newmark Composition for promoting prostate health containing selenium and herbal extracts
US6200573B1 (en) * 1999-12-03 2001-03-13 Starcor Pharmaceuticals, Inc. Method of medical management for lower urinary tract symptoms and benign prostatic hyperplasia

Also Published As

Publication number Publication date
PT1165108E (pt) 2003-10-31
EP1165108B1 (de) 2003-05-28
FR2791573B1 (fr) 2003-04-11
BR0009445A (pt) 2002-01-08
ATE241375T1 (de) 2003-06-15
AU774568B2 (en) 2004-07-01
JP2003504306A (ja) 2003-02-04
ES2199802T3 (es) 2004-03-01
EP1165108A1 (de) 2002-01-02
CN1346277A (zh) 2002-04-24
CA2370775A1 (fr) 2000-10-05
CA2370775C (fr) 2011-06-21
CN1261142C (zh) 2006-06-28
DE60003010D1 (de) 2003-07-03
DE60003010T2 (de) 2004-04-01
FR2791573A1 (fr) 2000-10-06
AU3663100A (en) 2000-10-16
US6599540B1 (en) 2003-07-29
WO2000057892A1 (fr) 2000-10-05
MXPA01009879A (es) 2002-05-06

Similar Documents

Publication Publication Date Title
DK1165108T3 (da) Anvendelse af et ekstrakt af Serenoa repens til fremstilling af et lægemiddel til behandling af prostatacancer
DK1169059T3 (da) Docetaxel i kombination med rhuMAb HER2 til behandling af cancere
MX2020009773A (es) Terapia de combinacion.
MXPA03003960A (es) Combinaciones de farmacos (v.gr., clorpromazina y pentamidina) para el tratamiento de desordenes neoplasticos.
NO20032027L (no) Effektive antitumorbehandlinger
CZ2000531A3 (en) Method of prevention or therapy of estrogen-dependent diseases and disorders
MY146533A (en) Use of docetaxel/doxorubicin/cyclophosphamide in adjuvant therapy of breast and ovarian cancer
HK1068606A1 (en) Novel aminobenzoephenones
IL125776A (en) Use of a cimicifuga racemosa extract for the manufacture of a drug for treating estrogen-dependent tumors
ATE344670T1 (de) Synergistische kombination zur behandlung von kolorektalkarzinom
MX2007006927A (es) Combinacion de inhibidor de tirosina cinasa y her-2/neu para terapia de cancer.
GB0020504D0 (en) Therapeutic method
DE60116075D1 (de) Behandlung von tumoren mit photodynamischer therapie
AU2020327022A8 (en) Method of treating cancer
PL357179A1 (en) Use of 2-methyl-thiazolidin-2,4-dicarboxylic acid (2-mtdc) and/or physiologically compatible salts for treating and/or preventing cancers
ATE345805T1 (de) Calciumtrifluoracetat mit zytotoxischer wirkung
HK1078022A1 (en) Compositions based on plant extracts for the treatment of cancer
DE60037402D1 (de) Behandlung von autoimmunkrankheiten mit einem extrakt von amerikanischem ginseng
DE60209757D1 (de) Prävention oder behandlung von brust-, prostata- und/oder gebärmutterhalskrebs mit n,n-dimethylglycin
UA34375A (uk) Спосіб лікування рака молочної залози
UA40393A (uk) Спосіб лікування хронічного обструктивного бронхіту